Emcure Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emcure Pharmaceuticals has submitted a routine compliance certificate to NSE and BSE from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited. The certificate confirms that share certificates received from depository participants for dematerialisation during the October–December 2025 quarter were processed, confirmed to the depositories, and listed on the stock exchanges. It also confirms that the physical certificates were mutilated and cancelled, and the depository's name was recorded as the registered owner in the company's register of members within the prescribed timelines. This is a standard quarterly filing required under SEBI's depository regulations and carries no business or financial numbers.
This is a routine procedural compliance filing with no material impact on the company's financials, operations, or share price. Investors can ignore it as a standard regulatory formality confirming smooth demat operations.